198 related articles for article (PubMed ID: 33993303)
1. Plasma C-Terminal Agrin Fragment as an Early Biomarker for Sarcopenia: Results From the GenoFit Study.
Pratt J; De Vito G; Narici M; Segurado R; Pessanha L; Dolan J; Conroy J; Boreham C
J Gerontol A Biol Sci Med Sci; 2021 Nov; 76(12):2090-2096. PubMed ID: 33993303
[TBL] [Abstract][Full Text] [Related]
2. C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction.
Drey M; Sieber CC; Bauer JM; Uter W; Dahinden P; Fariello RG; Vrijbloed JW;
Exp Gerontol; 2013 Jan; 48(1):76-80. PubMed ID: 22683512
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older multimorbid community-dwellers: Results from the ilSIRENTE study.
Landi F; Calvani R; Lorenzi M; Martone AM; Tosato M; Drey M; D'Angelo E; Capoluongo E; Russo A; Bernabei R; Onder G; Marzetti E
Exp Gerontol; 2016 Jun; 79():31-6. PubMed ID: 27015736
[TBL] [Abstract][Full Text] [Related]
4. Plasma neurofilament light levels associate with muscle mass and strength in middle-aged and older adults: findings from GenoFit.
Pratt J; De Vito G; Segurado R; Pessanha L; Dolan J; Narici M; Boreham C
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1811-1820. PubMed ID: 35415973
[TBL] [Abstract][Full Text] [Related]
5. Plasma C-terminal agrin fragment concentrations across adulthood: Reference values and associations with skeletal muscle health.
Pratt J; Motanova E; Pessanha L; Narici M; Boreham C; De Vito G
J Cachexia Sarcopenia Muscle; 2024 Jun; ():. PubMed ID: 38845597
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients.
Marzetti E; Calvani R; Lorenzi M; Marini F; D'Angelo E; Martone AM; Celi M; Tosato M; Bernabei R; Landi F
Exp Gerontol; 2014 Dec; 60():79-82. PubMed ID: 25304331
[TBL] [Abstract][Full Text] [Related]
7. Genes encoding agrin (AGRN) and neurotrypsin (PRSS12) are associated with muscle mass, strength and plasma C-terminal agrin fragment concentration.
Pratt J; Whitton L; Ryan A; Juliusdottir T; Dolan J; Conroy J; Narici M; De Vito G; Boreham C
Geroscience; 2023 Jun; 45(3):1289-1302. PubMed ID: 36609795
[TBL] [Abstract][Full Text] [Related]
8. C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review.
Monti E; Sarto F; Sartori R; Zanchettin G; Löfler S; Kern H; Narici MV; Zampieri S
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):730-744. PubMed ID: 36772862
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients.
Hettwer S; Dahinden P; Kucsera S; Farina C; Ahmed S; Fariello R; Drey M; Sieber CC; Vrijbloed JW
Exp Gerontol; 2013 Jan; 48(1):69-75. PubMed ID: 22433628
[TBL] [Abstract][Full Text] [Related]
10. Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
Steinbeck L; Ebner N; Valentova M; Bekfani T; Elsner S; Dahinden P; Hettwer S; Scherbakov N; Schefold JC; Sandek A; Springer J; Doehner W; Anker SD; von Haehling S
Eur J Heart Fail; 2015 Dec; 17(12):1283-93. PubMed ID: 26449626
[TBL] [Abstract][Full Text] [Related]
11. Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function.
Monti E; Tagliaferri S; Zampieri S; Sarto F; Sirago G; Franchi MV; Ticinesi A; Longobucco Y; Adorni E; Lauretani F; Von Haehling S; Marzetti E; Calvani R; Bernabei R; Cesari M; Maggio M; Narici MV
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):794-804. PubMed ID: 36708273
[TBL] [Abstract][Full Text] [Related]
12. Testosterone does not affect agrin cleavage in mobility-limited older men despite improvement in physical function.
Gagliano-Jucá T; Storer TW; Pencina KM; Travison TG; Li Z; Huang G; Hettwer S; Dahinden P; Bhasin S; Basaria S
Andrology; 2018 Jan; 6(1):29-36. PubMed ID: 28950424
[TBL] [Abstract][Full Text] [Related]
13. Effect of targeted intervention on C-terminal agrin fragment and its association with the components of sarcopenia: a scoping review.
Kumar P; Nayak K; Umakanth S; Girish N
Aging Clin Exp Res; 2023 Jun; 35(6):1161-1186. PubMed ID: 36977974
[TBL] [Abstract][Full Text] [Related]
14. Circulating C-Terminal Agrin Fragment: A Potential Marker for Sarcopenia Among Type 2 Diabetes.
Racha P; Selvam S; Bose B; Bantwal G; Sambashivaiah S
Indian J Endocrinol Metab; 2022; 26(4):334-340. PubMed ID: 36185967
[TBL] [Abstract][Full Text] [Related]
15. Grip strength performance from 9431 participants of the GenoFit study: normative data and associated factors.
Pratt J; De Vito G; Narici M; Segurado R; Dolan J; Conroy J; Boreham C
Geroscience; 2021 Oct; 43(5):2533-2546. PubMed ID: 34213693
[TBL] [Abstract][Full Text] [Related]
16. Active older dancers have lower C-terminal Agrin fragment concentration, better balance and gait performance than sedentary peers.
Marcolin G; Franchi MV; Monti E; Pizzichemi M; Sarto F; Sirago G; Paoli A; Maggio M; Zampieri S; Narici M
Exp Gerontol; 2021 Oct; 153():111469. PubMed ID: 34246731
[TBL] [Abstract][Full Text] [Related]
17. The Reference Intervals for Serum C-Terminal Agrin Fragment in Healthy Individuals and as a Biomarker for Renal Function in Kidney Transplant Recipients.
Yu D; Li HX; Liu Y; Ying ZW; Guo JJ; Cao CY; Wang J; Li YF; Yang HR
J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27638235
[TBL] [Abstract][Full Text] [Related]
18. Defining sarcopenia in terms of skeletal health.
Kim JH; Hong AR; Choi HJ; Ku EJ; Lee JH; Cho NH; Shin CS
Arch Osteoporos; 2018 Sep; 13(1):100. PubMed ID: 30238222
[TBL] [Abstract][Full Text] [Related]
19. Decreased Serum Levels of C-Terminal Agrin in Postmenopausal Women Following Resistance Training.
Willoughby DS; Beretich KN; Chen M; Funderburk LK
J Aging Phys Act; 2020 Jan; 28(1):73-80. PubMed ID: 31629361
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic measures for sarcopenia and bone mineral density.
Bijlsma AY; Meskers MC; Molendijk M; Westendorp RG; Sipilä S; Stenroth L; Sillanpää E; McPhee JS; Jones DA; Narici M; Gapeyeva H; Pääsuke M; Seppet E; Voit T; Barnouin Y; Hogrel JY; Butler-Browne G; Maier AB
Osteoporos Int; 2013 Oct; 24(10):2681-91. PubMed ID: 23649802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
